Tokio Marine Asset Management Co. Ltd. Boosts Stock Position in Avantor, Inc. (NYSE:AVTR)

Tokio Marine Asset Management Co. Ltd. increased its stake in Avantor, Inc. (NYSE:AVTRFree Report) by 3.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 18,725 shares of the company’s stock after buying an additional 685 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Avantor were worth $427,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in AVTR. Asset Management One Co. Ltd. grew its stake in shares of Avantor by 1.7% in the 3rd quarter. Asset Management One Co. Ltd. now owns 264,144 shares of the company’s stock worth $5,568,000 after buying an additional 4,349 shares during the last quarter. Handelsbanken Fonder AB grew its stake in shares of Avantor by 169.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 131,716 shares of the company’s stock worth $2,777,000 after buying an additional 82,843 shares during the last quarter. Commonwealth Equity Services LLC bought a new position in Avantor in the 3rd quarter valued at approximately $207,000. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in Avantor by 9.8% in the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 159,187 shares of the company’s stock valued at $3,356,000 after acquiring an additional 14,200 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its position in Avantor by 52.5% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 19,015 shares of the company’s stock valued at $401,000 after acquiring an additional 6,543 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.50% of the stock is owned by insiders.

Avantor Price Performance

Shares of Avantor stock opened at $23.94 on Monday. Avantor, Inc. has a one year low of $16.63 and a one year high of $26.16. The stock’s fifty day moving average is $25.08 and its 200 day moving average is $22.63. The stock has a market cap of $16.24 billion, a P/E ratio of 61.38, a P/E/G ratio of 2.44 and a beta of 1.37. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61.

Avantor (NYSE:AVTRGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the firm earned $0.29 EPS. Avantor’s revenue for the quarter was down 5.6% compared to the same quarter last year. Sell-side analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Raymond James upped their price objective on Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research report on Friday, January 26th. UBS Group upped their price objective on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Evercore ISI upped their price objective on Avantor from $26.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Barclays upped their price objective on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. Finally, Robert W. Baird upped their price objective on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.71.

Check Out Our Latest Stock Report on Avantor

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Further Reading

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.